drugset
drugset / Trial / NCT01925859

EryDex Pharmacokinetics in Healthy Volunteers

NCT01925859 ↗

Phase 1 Completed 18 enrolled Quince Therapeutics S.p.A.
NaSingle-groupOpen-labelTreatment

Summary

To compare the pharmacokinetic properties of two different doses of EryDex (dexamethasone sodium phosphate encapsulated in erythrocytes) given as a single infusion in healthy volunteers, based on plasma concentrations of dexamethasone.

Timeline

Start
2013-06
Primary completion
2013-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 50 mg Other
Subject Dexamethasone Small molecule 125 mg Other

Indications

No indication recorded.